biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Chiesi

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 09, 2023 10:56pm

98 Views

Post# 35212590

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Chiesi

So, you're saying that Saltarelli set this madness in motion?

And that LT and The Placee are just helping their friend Saltarelli out, a friend who thinks that xB3 is better than Denali's technology?

Like to have been there for that little meet.

jd

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management